In addition to providing, to our knowledge, the first evidence for the cell-intrinsic effects of DNMT3A mutations on peripheral blood cell subsets in patients with heart failure, the experimental approach may be helpful to address the effects of the various CHIP driver genes in a disease context. The gene discussed is DNMT3A; the disease is heart failure.